-
In the Moment- Winter 2013/2014Owen Dodd, Mike Rose, Lauren May
-
A Clear VisionAsking the right questions can help patients living with metastatic cancer understand the risks and benefits of recommended treatments and formulate their goals more effectively.
by Charlotte Huff
-
Beyond SurvivalAs cancer survivor numbers grow and longevity increases, researchers study how to ease symptoms and side effects.
by Melissa Weber
-
Survivor Profile
Betting on ScienceDiagnosed with a rare and incurable blood cancer, Jack Whelan is a passionate booster for research, clinical trials and affordable treatments.
by Betty Russell
-
Yesterday & Today
From Desire to DaisyWhether it was a star turn playing Blanche DuBois or Daisy Werthan, Jessica Tandy sparkled in a tough role. That didn't change after her cancer diagnosis.
by Karen Patterson
-
In the Moment- Fall 2013Oscar Llerena, Kimberlee Eshbaugh, Julie Garrabrant.
-
In the Moment- Summer 2013Matt Hiznay, Diane Fowler, Roxann Merino.
-
Forward Look
When the Cancer Doctor Gets CancerQ & A with breast surgeon Susan Love on her new role: cancer survivor.
by Betty Russell
-
The Power of OneA cancer survivor reflects on the stranger who gave him a second chance at life.
by Robert Henslin
-
Reimagine Your BodyHelp is available for cancer patients worried about how they look during and after treatment.
by Melissa Weber
Scientists present data on the risks of immune checkpoint inhibitors so more patients can tap into the treatment.
by Marci A. Landsmann
Tissue and Liquid Biopsy for Targeted TherapyTailored treatments led to better outcomes than standard of care when biomarker results from liquid biopsy and tumor tissue aligned.
by Eric Fitzsimmons
Cancer Vaccines Show Promise in Early TrialsWhile mRNA vaccines offer a personalized approach to triggering an immune response, peptide vaccines could be a one-size-fits-all treatment. Researchers are exploring both options.
by Thomas Celona
Declining Breast Cancer Mortality in Younger WomenU.S. breast cancer deaths declined for women ages 20 to 49, which researchers credit to wider screening and better treatment.
by Kevin McLaughlin
-
Inaugural AACR IO Conference Kicks Off With Celebration of Immune CheckpointsImmune checkpoint icons James Allison and Arlene Sharpe shared their journeys and a look ahead on the opening night of the inaugural AACR IO conference.
-
A New Resource Provides a Sanctuary for Black TNBC PatientsThe Black TNBC Sanctuary was created to help Black women with triple-negative breast cancer get answers about their diagnosis and care.
Dr. Humberto M. Guiot: Targeting Pancreatic Cancer in a Community-Based Clinical Trial
